Pharmacotherapy for Respiratory Disorders

  • Uncategorized

Pharmacotherapy for Respiratory Disorders 1

Pharmacotherapyfor Respiratory Disorders

ChronicBronchitis

Itis a part of the Chronic Obstructive Pulmonary Diseases, and it’salso a common cause of death in America. Typically, it is arespiratory disorder whereby the mucus membrane and the bronchialpassages become inflamed. It is an acute long-term disease that needsa regular medical attention (Arcangelo,et al. 2006).

Someof the drugs that are regularly prescribed for this types of patientsinclude the Bronchodilators. Bronchodilators are drugs such asalbuterol and metaproterenol. These drugs activity is by relaxationof the smooth muscles that surrounds the bronchi then allow the innerair pathways to expand (DiPiro,et al. 2000).Besides, steroids such as prednisone decrease the inflammatoryreaction and, in turn, reduce bronchial swelling.

Factorthat might impact the effect of the prescribed drug

Age

Typically,age might impact the effects of the steroids and the bronchodilators.For the younger individuals, broadly from 10-40 years, the drugsmight have little side effects because their body responds to thedrug well and it`s able to break down its components into smallerunits. However, for the older people, their body system does notallow the multiplication of cells easily and thus the damage causedby the drug is difficult to be recovered (Celli,et al. 2008).Therefore, these drugs are much effective for the younger peoplecompared to the elderly because of the activity of their bodycells(bronchial cells).

Tocurb this side effects, the physicians will prefer a pulmonaryrehabilitation that encompasses physical exercise and also education.In this therapy, the patient is advised to participate in sportingactivities so that they can keep their bodies in a healthy state.Additionally, for the case of smokers, they are always givenappropriate education regarding the side effects that smoking causesto them (Diakides,et al. 2012).Physical exercise is important since it helps in breaking down thedrug and thus avoids the buildup of the toxic compounds in the body.

Conclusion

Generally,chronic bronchitis is a respiratory disease that if left untreated,it can lead to death of an individual. Therefore, appropriatemeasures should be taken once the disorder is diagnosed. Research hasshown that it is possible to treat this disorder by usingtherapeutics.

References

Arcangelo,V. P., &amp Peterson, A. M. (Eds.). (2006).&nbspPharmacotherapeuticsfor advanced practice: a practical approach&nbsp(Vol.536). Lippincott Williams &amp Wilkins.

Celli,B. R., Thomas, N. E., Anderson, J. A., Ferguson, G. T., Jenkins, C.R., Jones, P. W., … &amp Calverley, P. M. (2008). Effect ofpharmacotherapy on rate of decline of lung function in chronicobstructive pulmonary disease: results from the TORCH study.&nbspAmericanjournal of respiratory and critical care medicine,&nbsp178(4),332-338.

Diakides,M., Bronzino, J. D., &amp Peterson, D. R. (Eds.). (2012).&nbspMedicalInfrared Imaging: Principles and Practices.CRC press.

DiPiro,J. T., Schwinghammer, T. L., &amp Hamilton, C. W.(2000).Pharmacotherapyhandbook.Appleton &amp Lange.

Close Menu